Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Ltd.
NSE: LUPIN
|
BSE: 500257
|
ISIN: INE326A01037
|
Industry: Pharmaceuticals
US FDA Approval
|
Mid-range Performer
1954.8000
-13.60
(
-0.69
%)
NSE
Jul 03, 2025
15:31 PM
Volume:
739.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Lupin Ltd.
14 Aug 2018
US FDA Approval
1954.80
-0.69%
Lupin Limited
Results Update:
Lupin Ltd.
by
SMC online
SMC online
Lupin Ltd.'s price crossed below 30Day SMA today
More from Lupin Ltd.
Recommended
Market closes lower, PN Gadgil Jewellers to raise Rs 1,000 crore via QIP or other modes
Trendlyne Marketwatch |
03 Jul 2025, 04:04PM
Is India getting old before getting rich? | Screener: All star stocks with high five year returns
The Baseline |
03 Jul 2025, 12:14PM
Lupin expects normalization by September quarter
|
17 Apr 2020